Skip to content

NCEL

NewCelX Ltd.

NASDAQ · Healthcare · Biotechnology · CH

$3.15
−6.80%
Ask drillr

Next report

Analyst consensus

Next report date
Mar 3, 2027
EPS estimate
-$0.65
Revenue estimate

Latest reported

Last report date
Sep 18, 2026
EPS actual
-$0.53
EPS estimate
-$0.53
Revenue actual
Revenue estimate

Track record

Trailing twelve quarters

EPS beats (12Q)
4
EPS misses (12Q)
0
EPS in line (12Q)
1
Avg surprise (4Q)
+73.5%
Revenue beats (12Q)
Earnings call history

No earnings call summaries available

Reported history
Report dateEPS estimateEPS actualSurpriseRevenue actual
Sep 18, 2026-$0.53-$0.53In line
May 15, 2024-$8.40-$0.00Beat 100.00%
May 5, 2023-$12-$0.29Beat 97.55%
Oct 11, 2022-$0.54
Mar 24, 2022-$14-$0.50Beat 96.39%
May 14, 2021-$6.80-$0.34Beat 95.03%
Jun 29, 2019-$0.31

Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Mar 3, 2027